Our top pick for
Luxfer Holdings PLC is a specialty industrial machinery business based in the US. Luxfer shares (LXFR) are listed on the NYSE and all prices are listed in US Dollars. Luxfer employs 1,200 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$21.19|
|52-week range||$11.45 - $23.63|
|50-day moving average||$20.32|
|200-day moving average||$21.11|
|Wall St. target price||$27.67|
|Dividend yield||$0.5 (2.38%)|
|Earnings per share (TTM)||$1.25|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-14)||0.76%|
|1 month (2021-09-21)||11.94%|
|3 months (2021-07-21)||1.48%|
|6 months (2021-04-21)||1.83%|
|1 year (2020-10-21)||59.08%|
|2 years (2019-10-21)||30.00%|
|3 years (2018-10-19)||22.37|
|5 years (2016-10-21)||125.67%|
Valuing Luxfer stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Luxfer's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Luxfer's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 17x. In other words, Luxfer shares trade at around 17x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Luxfer's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.0253. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Luxfer's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Luxfer's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $62.4 million.
The EBITDA is a measure of a Luxfer's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$344 million|
|Operating margin TTM||14.04%|
|Gross profit TTM||$80.9 million|
|Return on assets TTM||8.14%|
|Return on equity TTM||16.32%|
|Market capitalisation||$592.7 million|
TTM: trailing 12 months
There are currently 367,180 Luxfer shares held short by investors – that's known as Luxfer's "short interest". This figure is 18% up from 311,059 last month.
There are a few different ways that this level of interest in shorting Luxfer shares can be evaluated.
Luxfer's "short interest ratio" (SIR) is the quantity of Luxfer shares currently shorted divided by the average quantity of Luxfer shares traded daily (recently around 66518.115942029). Luxfer's SIR currently stands at 5.52. In other words for every 100,000 Luxfer shares traded daily on the market, roughly 5520 shares are currently held short.
However Luxfer's short interest can also be evaluated against the total number of Luxfer shares, or, against the total number of tradable Luxfer shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Luxfer's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Luxfer shares in existence, roughly 10 shares are currently held short) or 0.0146% of the tradable shares (for every 100,000 tradable Luxfer shares, roughly 15 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Luxfer.
Find out more about how you can short Luxfer stock.
Dividend payout ratio: 39.37% of net profits
Recently Luxfer has paid out, on average, around 39.37% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.34% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Luxfer shareholders could enjoy a 2.34% return on their shares, in the form of dividend payments. In Luxfer's case, that would currently equate to about $0.5 per share.
While Luxfer's payout ratio might seem fairly standard, it's worth remembering that Luxfer may be investing much of the rest of its net profits in future growth.
Luxfer's most recent dividend payout was on 3 August 2021. The latest dividend was paid out to all shareholders who bought their shares by 13 October 2021 (the "ex-dividend date").
Over the last 12 months, Luxfer's shares have ranged in value from as little as $11.4507 up to $23.6318. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Luxfer's is 0.9886. This would suggest that Luxfer's shares are less volatile than average (for this exchange).
Luxfer Holdings PLC, together with its subsidiaries, designs, manufactures, and supplies high-performance materials, components, and high-pressure gas containment devices for defense and emergency response, healthcare, transportation, and general industrial end-market applications. It operates in two segments, Gas Cylinders and Elektron. The Gas Cylinders segment manufactures and markets carbon composite cylinders for self-contained breathing apparatus that are used by firefighters and other emergency-responders, as well as scuba divers and personnel in hazardous environments, such as mines; and cylinders used for containment of oxygen and other medical gases used by patients, healthcare facilities, and laboratories. This segment also offers carbon composite cylinders for compressed natural gas and hydrogen containment in alternative fuel vehicles. The Elektron segment focuses on specialty materials based on magnesium, zircon sand, and rare earths. It develops and manufactures magnesium alloys for use in variety of industries; magnesium powders for use in countermeasure flares and heater meals; and magnesium, copper, and zinc photoengraving plates for graphic arts and luxury packaging. This segment also develops and manufactures zirconium-based materials and oxides used as catalysts and in the manufacture of advanced ceramics, fiber-optic fuel cells, and other performance products.
Everything we know about the Aura Biosciences IPO, plus information on how to buy in.
Everything we know about the Claros Mortgage Trust IPO, plus information on how to buy in.
Everything we know about the Evotec SE IPO, plus information on how to buy in.
Everything we know about the Delimobil Holding SA IPO, plus information on how to buy in.
Everything we know about the Blue Water Vaccines IPO, plus information on how to buy in.
Everything we know about the Sonendo IPO, plus information on how to buy in.
Everything we know about the FlexEnergy Green Solutions IPO, plus information on how to buy in.
Everything we know about the Stran & Company IPO, plus information on how to buy in.
Everything we know about the Kidpik Corp IPO, plus information on how to buy in.
Everything we know about the Nuvectis Pharma IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.